Valiant Laboratories Ltd (VALIANTLAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 10039033, "name": "Valiant Laborato", "stock_name": "Valiant Laborato", "full_name": "Valiant Laboratories Ltd", "name_url": "stocks-analysis/valiant-laborato", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "61.10", "chg": 5.81, "chgp": "10.51%", "dir": 1, "prev_price": "55.29", "mcapval": "315.00 Cr", "mcap": "Micro Cap", "scripcode": 543998, "symbol": "VALIANTLAB", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE0JWS01017", "curr_date": "Mar 20", "curr_time": "", "bse_nse_vol": "6.56 lacs", "exc_status": "Active", "traded_date": "Mar 20, 2026", "traded_date_str": "2026 03 20", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/valiant-laborato-10039033-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Valiant Laboratories Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/valiant-laboratories-ltd-is-rated-strong-sell-3884930", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ValiantLaborato_mojoScore_3884930.png", "date": "2026-03-11 10:10:17", "description": "Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 11 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Valiant Laboratories Ltd Falls 5.14% Amid New Lows and Weak Financials", "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-falls-514-amid-new-lows-and-weak-financials-3878043", "imagepath": "", "date": "2026-03-07 11:01:57", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Mar:</strong> New 52-week low at Rs.55</p>\n <p><strong>4 Mar:</strong> Stock hits all-time low of Rs.50 amid heavy losses</p>\n <p><strong>4 Mar:</strong> Sharp intraday volatility and sector underperformance</p>\n <p><strong>6 Mar:</strong> Week closes at Rs.54.04, down 0.95% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.56.97</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.54.04</div><div class=\"stat-change neg..." }, { "title": "Valiant Laboratories Ltd Stock Falls to 52-Week Low of Rs.50", "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-stock-falls-to-52-week-low-of-rs50-3869843", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ValiantLaborato_priceRelatedfactors_3869843.png", "date": "2026-03-04 12:28:53", "description": "Valiant Laboratories Ltd’s shares plunged to a fresh 52-week low of Rs.50 on 4 March 2026, marking a significant decline amid persistent underperformance and weak financial metrics. The stock’s fall reflects ongoing pressures within the Pharmaceuticals & Biotechnology sector, with the company’s valuation and profitability indicators signalling challenges in the near term." }, { "title": "Valiant Laboratories Ltd Stock Falls to 52-Week Low of Rs.50", "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-stock-falls-to-52-week-low-of-rs50-3869847", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ValiantLaborato_priceRelatedfactors_3869847.png", "date": "2026-03-04 12:28:46", "description": "Valiant Laboratories Ltd has touched a new 52-week low of Rs.50 today, marking a significant decline in its share price amid persistent downward momentum. The stock’s performance continues to lag behind its sector and broader market indices, reflecting ongoing pressures on the company’s financial and operational metrics." }, { "title": "Valiant Laboratories Ltd Stock Hits All-Time Low Amid Continued Downtrend", "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-stock-hits-all-time-low-amid-continued-downtrend-3868683", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ValiantLaborato_priceRelatedfactors_3868683.png", "date": "2026-03-04 09:52:36", "description": "Valiant Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recorded a new all-time low of Rs.50, marking a significant downturn in its stock performance. The steep decline reflects ongoing difficulties faced by the company, with its shares underperforming both the sector and broader market indices over multiple time frames." }, { "title": "Valiant Laboratories Ltd Falls to 52-Week Low of Rs 55", "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-falls-to-52-week-low-of-rs-55-3865009", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ValiantLaborato_priceRelatedfactors_3865009.png", "date": "2026-03-02 13:11:24", "description": "Valiant Laboratories Ltd has reached a new 52-week low of Rs.55, marking a significant decline in its stock price amid ongoing underperformance relative to its sector and benchmark indices. The stock’s recent trajectory reflects a series of financial and market pressures that have weighed on investor sentiment and valuation metrics." }, { "title": "Valiant Laboratories Ltd Falls 3.56%: 3 Key Factors Driving the Week’s Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-falls-356-3-key-factors-driving-the-weeks-decline-3861923", "imagepath": "", "date": "2026-02-28 10:01:30", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>23 Feb:</strong> Stock hits 52-week and all-time low at Rs.55.85</p>\n <p><strong>24-26 Feb:</strong> Price stabilises near Rs.59.50 with muted volume</p>\n <p><strong>27 Feb:</strong> Stock falls sharply to Rs.56.97, marking fresh 52-week low</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.59.07</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.56.97</div><div class=\"stat-change negative\">-3.56%</div></div>\n <div class=\"stat-ite..." }, { "title": "Valiant Laboratories Ltd Stock Falls to 52-Week Low Amidst Continued Weakness", "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-stock-falls-to-52-week-low-amidst-continued-weakness-3860527", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ValiantLaborato_priceRelatedfactors_3860527.png", "date": "2026-02-27 16:01:57", "description": "Valiant Laboratories Ltd has reached a new 52-week low, with its share price touching an intraday low of ₹56.5, marking a significant decline amid ongoing pressures in the Pharmaceuticals & Biotechnology sector. The stock closed just 1.95% above its 52-week low of ₹55.85, reflecting sustained weakness over the past year." }, { "title": "Valiant Laboratories Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/valiant-laboratories-ltd-is-rated-strong-sell-3860030", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ValiantLaborato_mojoScore_3860030.png", "date": "2026-02-27 10:10:17", "description": "Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 27 February 2026, providing investors with the latest perspective on the company’s position." } ], "total": 298, "sid": "10039033", "stock_news_url": "https://www.marketsmojo.com/news/valiant-laboratories-10039033" }, "announcements": "", "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Valiant Laboratories Ltd has announced <strong>1:4</strong> rights issue, ex-date: 18 Jul 25", "dt": "2025-07-18", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

2 Mar: New 52-week low at Rs.55

4 Mar: Stock hits all-time low of Rs.50 amid heavy losses

4 Mar: Sharp intraday volatility and sector underperformance

6 Mar: Week closes at Rs.54.04, down 0.95% on the day

Read full news article

Valiant Laboratories Ltd Stock Falls to 52-Week Low of Rs.50

2026-03-04 12:28:53

Valiant Laboratories Ltd’s shares plunged to a fresh 52-week low of Rs.50 on 4 March 2026, marking a significant decline amid persistent underperformance and weak financial metrics. The stock’s fall reflects ongoing pressures within the Pharmaceuticals & Biotechnology sector, with the company’s valuation and profitability indicators signalling challenges in the near term.

Read full news article

Valiant Laboratories Ltd Stock Falls to 52-Week Low of Rs.50

2026-03-04 12:28:46

Valiant Laboratories Ltd has touched a new 52-week low of Rs.50 today, marking a significant decline in its share price amid persistent downward momentum. The stock’s performance continues to lag behind its sector and broader market indices, reflecting ongoing pressures on the company’s financial and operational metrics.

Read full news article

Valiant Laboratories Ltd Stock Hits All-Time Low Amid Continued Downtrend

2026-03-04 09:52:36

Valiant Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recorded a new all-time low of Rs.50, marking a significant downturn in its stock performance. The steep decline reflects ongoing difficulties faced by the company, with its shares underperforming both the sector and broader market indices over multiple time frames.

Read full news article

Valiant Laboratories Ltd Falls to 52-Week Low of Rs 55

2026-03-02 13:11:24

Valiant Laboratories Ltd has reached a new 52-week low of Rs.55, marking a significant decline in its stock price amid ongoing underperformance relative to its sector and benchmark indices. The stock’s recent trajectory reflects a series of financial and market pressures that have weighed on investor sentiment and valuation metrics.

Read full news article

Valiant Laboratories Ltd Falls 3.56%: 3 Key Factors Driving the Week’s Decline

2026-02-28 10:01:30

Key Events This Week

23 Feb: Stock hits 52-week and all-time low at Rs.55.85

24-26 Feb: Price stabilises near Rs.59.50 with muted volume

27 Feb: Stock falls sharply to Rs.56.97, marking fresh 52-week low

Read full news article

Valiant Laboratories Ltd Stock Falls to 52-Week Low Amidst Continued Weakness

2026-02-27 16:01:57

Valiant Laboratories Ltd has reached a new 52-week low, with its share price touching an intraday low of ₹56.5, marking a significant decline amid ongoing pressures in the Pharmaceuticals & Biotechnology sector. The stock closed just 1.95% above its 52-week low of ₹55.85, reflecting sustained weakness over the past year.

Read full news article

Valiant Laboratories Ltd is Rated Strong Sell

2026-02-27 10:10:17

Valiant Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 27 February 2026, providing investors with the latest perspective on the company’s position.

Read full news article

View All News